Urine α-fetoprotein and orosomucoid 1 as biomarkers of hepatitis B virus-associated hepatocellular carcinoma

被引:29
|
作者
Zhan, Zhu [1 ,2 ,3 ]
Guan, Yalan [1 ,2 ,3 ]
Mew, Kenley [4 ]
Zeng, Weigiong [1 ,2 ,3 ]
Peng, Mingli [1 ,2 ,3 ]
Hu, Peng [1 ,2 ,3 ]
Yang, Yixuan [1 ,2 ,3 ]
Lu, Yi [1 ,2 ,3 ]
Ren, Hong [1 ,2 ,3 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 2, Dept Infect Dis, Chongqing, Peoples R China
[2] Chongqing Med Univ, Inst Viral Hepatitis, Chongqing, Peoples R China
[3] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Minist Educ, Chongqing, Peoples R China
[4] Chongqing Med Univ, Dept Foreign Language, Chongqing, Peoples R China
关键词
biomarker; hepatocellular carcinoma; proteomic; urine; alpha-fetoprotein; CLINICAL-PRACTICE GUIDELINES; ALPHA-1-ACID GLYCOPROTEIN; PROTEIN; COMBINATION; MANAGEMENT;
D O I
10.1152/ajpgi.00267.2019
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocellular carcinoma (HCC) is the sixth common malignant tumor worldwide. but current efficient and convenient screening methods remain lacking. This study aimed to discover a diagnostic or a screening biomarker from the urine of hepatitis B virus (HBV)-related HCC patients. We used iTRAQ coupled with mass spectrometry to identify candidate urinary proteins in a discovery cohort (n = 40). The selected proteins were confirmed using ELISA in a validation cohort (n = 140). Diagnostic performance of the selected proteins was assessed using receiver operating characteristic (ROC) and qualitative diagnostic analysis. A total of 96 differentially expressed proteins were identified. Urinary alpha-fetoprotein (u-AFP) and orosomucoid 1 (u-ORM1) were selected as target proteins by bioinformatics analysis and were significantly higher in HCC than in non-HCC patients, as validated by Western blot analysis and ELISA. u-AFP had a strong correlation with serum AFP-L3 (Pearson's r = 0.944, P < 0.0001), indicating that u-AFP may be derived from circulating blood. The area under the curve (AUC) of u-AFP was 0.795 with a sensitivity of 62.5% and a specificity of 95.4%, which showed no significantly difference with scrum AFP (se-AFP). The AUC was 0.864 as u-AFP and u-ORM1 were combined, and they performed much better than u-AFP or u-ORM1 alone. Qualitative diagnostic analysis showed that the positive predictive value of u-AFP was 90.1% and the diagnostic sensitivity of parallel combination of u-AFP and u-ORM1 was 85.1%. Taken together, AFP and ORM1 in the urine may be used as a diagnostic or screening biomarker of HCC, and studies on large samples are needed to validate the result. NEW & NOTEWORTHY This study provides a novel way to find biomarkers of hepatocellular carcinoma (HCC) and a new perspective of alpha-fetoprotein clinical application. The urine reagent strips may be helpful in high epidemic areas of HCC and in low-resource settings.
引用
收藏
页码:G305 / G312
页数:8
相关论文
共 50 条
  • [21] Expression and significance of caveolin-1 in hepatitis B virus-associated hepatocellular carcinoma
    Cheng, Hao
    Pan, Yiming
    Yao, Yongzhong
    Zhu, Zhanghua
    Chen, Jun
    Sun, Xitai
    Qiu, Yudong
    Ding, Yitao
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (05) : 4356 - 4362
  • [22] Current Advancements in Serum Protein Biomarkers for Hepatitis B Virus-Associated Hepatocyte Remodeling and Hepatocellular Carcinoma
    Adugna, Adane
    Amare, Gashaw Azanaw
    Jemal, Mohammed
    IMMUNITY INFLAMMATION AND DISEASE, 2025, 13 (04)
  • [23] Early and Late Recurrence of Hepatitis B Virus-Associated Hepatocellular Carcinoma
    Wang, Ming-Da
    Li, Chao
    Liang, Lei
    Xing, Hao
    Sun, Li-Yang
    Quan, Bing
    Wu, Han
    Xu, Xin-Fei
    Wu, Meng-Chao
    Pawlik, Timothy M.
    Lau, Wan Yee
    Shen, Feng
    Yang, Tian
    ONCOLOGIST, 2020, 25 (10): : E1541 - E1551
  • [24] Genetic and epigenetic alterations in hepatitis B virus-associated hepatocellular carcinoma
    Tian, Yongjun
    Ou, Jing-hsiung James
    VIROLOGICA SINICA, 2015, 30 (02) : 85 - 91
  • [25] Development of a nomogram for screening of hepatitis B virus-associated hepatocellular carcinoma
    Chung, Jung Wha
    Jang, Eun Sun
    Kim, Jaihwan
    Jeong, Sook-Hyang
    Kim, Nayoung
    Lee, Dong Ho
    Lee, Kyung Ho
    Kim, Jin-Wook
    ONCOTARGET, 2017, 8 (63) : 106499 - 106510
  • [26] Host Epigenetic Alterations and Hepatitis B Virus-Associated Hepatocellular Carcinoma
    Zeisel, Mirjam B.
    Guerrieri, Francesca
    Levrero, Massimo
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (08)
  • [27] Conceptual models for the initiation of hepatitis B virus-associated hepatocellular carcinoma
    Tu, Thomas
    Budzinska, Magdalena A.
    Shackel, Nicholas A.
    Jilbert, Allison R.
    LIVER INTERNATIONAL, 2015, 35 (07) : 1786 - 1800
  • [28] Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma
    Mathew, Shilu
    Abdel-Hafiz, Hany
    Raza, Abbas
    Fatima, Kaneez
    Qadri, Ishtiaq
    WORLD JOURNAL OF HEPATOLOGY, 2016, 8 (10) : 485 - 498
  • [29] Transgenic mouse models of hepatitis B virus-associated hepatocellular carcinoma
    Singh, M
    Kumar, V
    REVIEWS IN MEDICAL VIROLOGY, 2003, 13 (04) : 243 - 253
  • [30] Genetic and epigenetic alterations in hepatitis B virus-associated hepatocellular carcinoma
    Yongjun Tian
    Jing-hsiung James Ou
    Virologica Sinica, 2015, 30 (02) : 85 - 91